moatshark My

All holdings

Solventum

SOLV

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$1.1bn
Combined value at quarter end
Last quarter
0 bought
2 sold or trimmed
Fund portfolios
1
Funds holding it
See which
Price at Q2 ’26 end
$77.15
+18.1% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+31.8%Q3 ’24
-5.2%Q4 ’24
+15.1%Q1 ’25
-0.3%Q2 ’25
-3.7%Q3 ’25
+8.5%Q4 ’25
-17.6%Q1 ’26
+18.1%Q2 ’26
Q3 ’24: +31.8%; Q4 ’24: -5.2%; Q1 ’25: +15.1%; Q2 ’25: -0.3%; Q3 ’25: -3.7%; Q4 ’25: +8.5%; Q1 ’26: -17.6%; Q2 ’26: +18.1%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

0Q4 ’23
0Q1 ’24
6Q2 ’24
6Q3 ’24
4Q4 ’24
4Q1 ’25
3Q2 ’25
3Q3 ’25
3Q4 ’25
3Q1 ’26
3Q2 ’26
0Q3 ’26
Q4 ’23: 0; Q1 ’24: 0; Q2 ’24: 6; Q3 ’24: 6; Q4 ’24: 4; Q1 ’25: 4; Q2 ’25: 3; Q3 ’25: 3; Q4 ’25: 3; Q1 ’26: 3; Q2 ’26: 3; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Solventum.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Solventum
Trian Fund Management15.0%$635m$635mUnchanged9 qtrs
Davis Selected Advisers2.1%$487m$487mTrimmed -0.4%9 qtrs
Mairs & Power0.1%$5.6m$5.6mTrimmed -0.1%9 qtrs

Download the holders: CSV · JSON · Markdown

About the company

Sector
Health care · Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
170m at 31 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$8.1bn2022
$8.2bn2023
$8.3bn2024
$8.3bn2025
2022: $8.1bn; 2023: $8.2bn; 2024: $8.3bn; 2025: $8.3bn
Solventum revenue and net income by year
YearRevenueNet income
2025$8.3bn$1.6bn
2024$8.3bn$479m
2023$8.2bn$1.3bn
2022$8.1bn$1.3bn

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

In fund portfolios

US-registered funds run by these managers that hold Solventum, from their latest N-PORT filings.

Funds holding Solventum
Davis Global FundDavis Selected Advisers2.6%$24.5m31 Jul 2026